What is the recommendation for noncardioembolic stroke patients taking antiplatelet therapy?
For patients who have a noncardioembolic AIS while taking antiplatelet therapy, switching to warfarin is not indicated for secondary stroke prevention. This is a new recommendation and is rated as III: No Benefit B-NR.